Narayana Hrudayalaya Ltd.
NH · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹902.84.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%19.8%
- ✕Low debt (D/E < 0.5)1.29x
- ✓Positive free cash flow
- ✓Revenue growth > 10%76%
- ✓Earnings growing14%
- ✓Net margin ≥ 10%10.2%
- ✓Current ratio > 1.52.15
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 3.94
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Strong return on equity (19.8%).
- •Financially solid — Altman Z 3.94.
Weaknesses
- •High debt relative to equity.
Opportunities
- •Revenue growing (76% YoY).
Threats
- •Trades ~40% above our estimated fair value.
About Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, cri
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.